Myopericarditis following smallpox vaccination

American Journal of Epidemiology
Mark K ArnessDavid N Tornberg

Abstract

Myopericarditis has been a rare or unrecognized event after smallpox vaccinations with the New York City Board of Health strain of vaccinia virus (Dryvax; Wyeth Laboratories, Marietta, Pennsylvania). In this article, the authors report an attributable incidence of at least 140 clinical cases of myopericarditis per million primary smallpox vaccinations with this strain of vaccinia virus. Fifty-eight males and one female aged 21-43 years with confirmed or probable acute myopericarditis were detected following vaccination of 492,730 US Armed Forces personnel from December 15, 2002, through September 30, 2003. The cases were identified through sentinel reporting to military headquarters, active surveillance using the Defense Medical Surveillance System, or reports to the Vaccine Adverse Event Reporting System. The observed incidence (16.11/100,000) of myopericarditis over a 30-day observation window among 347,516 primary vaccinees was nearly 7.5-fold higher than the expected rate of 2.16/100,000 (95% confidence interval: 1.90, 2.34) among nonvaccinated, active-duty military personnel, while the incidence of 2.07/100,000 among 145,155 revaccinees was not statistically different from the expected background rate. The cases were predo...Continue Reading

Citations

Apr 10, 2009·The New England Journal of Medicine·Leslie T Cooper
Mar 20, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ismael R Ortega-SanchezGina T Mootrey
Mar 20, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Juliette MorganDavid L Swerdlow
Mar 20, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John NeffUNKNOWN Armed Forces Epidemiological Board
Mar 20, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Louisa E ChapmanRobert Shope
Oct 13, 2005·Southern Medical Journal·Benjamin J SilkRuth L Berkelman
Jul 31, 2008·The Pediatric Infectious Disease Journal·Michelle BartonRonald Gold
May 13, 2009·Southern Medical Journal·Luis F MoraLaurence S Sperling
Dec 4, 2004·BMJ : British Medical Journal·Paul E M Fine
Mar 3, 2005·Medical Immunology·Mark K Slifka
Dec 17, 2009·International Archives of Medicine·Hesham R OmarMohamed Elghonemy
Dec 29, 2006·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Nathaniel HupertSamuel Benson
Aug 29, 2006·PLoS Medicine·Mirjam KretzschmarRafael Mikolajczyk
Sep 24, 2010·Future Microbiology·Clement A Meseda, Jerry P Weir
May 20, 2009·Pharmacogenomics·Gregory A PolandRobert M Jacobson
Jul 19, 2005·Emerging Infectious Diseases·Frederick A Murphy, Bennie I Osburn
Jan 21, 2006·Emerging Infectious Diseases·Claude Chastel
Nov 28, 2014·Immunotherapy·Whitney L SimonGregory A Poland
Feb 15, 2013·Expert Review of Cardiovascular Therapy·Massimo Imazio, Leslie T Cooper
May 1, 2006·Expert Review of Clinical Immunology·J Michael Lane
Feb 7, 2008·Expert Review of Vaccines·John Iskander, Karen Broder
Dec 20, 2008·Expert Review of Vaccines·Jeffrey S Kennedy, Richard N Greenberg
Mar 28, 2008·Expert Opinion on Investigational Drugs·Richard N Greenberg, Jeffrey S Kennedy
Oct 14, 2008·Expert Opinion on Biological Therapy·Gregory A PolandRobert M Jacobson
Sep 3, 2013·The Journal of Emergency Medicine·David I Bruner, Bradley S Butler
Dec 9, 2008·Antiviral Research·Martina SpisakovaZora Melkova
Jan 29, 2008·International Journal of Cardiology·Massimo Imazio, Rita Trinchero
Nov 6, 2007·Vaccine·Robert E EckartJohn D Grabenstein
Sep 20, 2006·Emergency Medicine Clinics of North America·Mark A Saks, David Karras
Apr 18, 2009·Pharmacoepidemiology and Drug Safety·Alison Rue-CoverJane F Seward
Dec 13, 2006·Pharmacoepidemiology and Drug Safety·A W McMahonM M Braun
Feb 20, 2008·Reviews in Medical Virology·Andrew W Artenstein
Apr 20, 2005·Vaccine·Andrew W ArtensteinThomas P Monath
Oct 21, 2006·Vaccine·Julie KennerMarc Gurwith
Feb 7, 2006·Lancet·Zack S MooreJ Michael Lane

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American College of Cardiology
Robert E EckartDepartment of Defense Smallpox Vaccination Clinical Evaluation Team
JAMA : the Journal of the American Medical Association
Jeffrey S HalsellDepartment of Defense Smallpox Vaccination Clinical Evaluation Team
Journal of the American College of Cardiology
Dimitri C CassimatisMarina N Vernalis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Claudia VellozziChristine G Casey
© 2021 Meta ULC. All rights reserved